We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 2,239

Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • September 17 2018

Below is this week’s “Capitol Hill Healthcare Update,” posted on Mondays when Congress is in session. Featured in this week’s Update, the Senate votes


Employers’ Prescription Drug Use Policies Coming Under Scrutiny
  • Hunton Andrews Kurth LLP
  • USA
  • August 21 2018

As reported on the Hunton Employment & Labor Perspectives blog, the ongoing opioid epidemic is causing employers to consider the best ways to ensure a


Dutch competition authority ACM starts sector inquiry into anti-rheumatism drugs
  • Taylor Wessing
  • Netherlands
  • August 21 2018

In a previous edition of Synapse we already informed you about the fact that the Dutch Authority for Consumer and Market ("ACM") announced in its


New Proposition 65 warning requirements take effect on August 30, 2018
  • Atkinson Andelson Loya Ruud & Romo
  • USA
  • August 15 2018

On August 30, 2018, new regulations under California's Safe Drinking Water and Toxic Enforcement Act, better known as Proposition 65 ("Prop. 65")


Employers’ Prescription Drug Use Policies Coming Under Scrutiny
  • Hunton Andrews Kurth LLP
  • USA
  • August 9 2018

The opioid epidemic is causing employers to consider the best ways to ensure a safe workplace, but companies should be careful when addressing


Be Careful What You Ask For
  • Dechert LLP
  • USA
  • August 7 2018

Today’s post is an update to our post from just a few weeks ago regarding McWilliams v. Novartis AG, No. 2:17-CV-14302 (S.D. Fla.). At that time, the


Employee Benefits Newsletter - Summer 2018
  • Jackson Lewis PC
  • USA
  • July 19 2018

In this Issue New Agency Guidance Makes Mental Health Parity and Addiction Equity Act Enforcement a Priority Finding Missing Participants in a


FDA Draft Guidance on Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • July 17 2018

On July 3, 2018, the FDA issued draft guidance on Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products. The


Arrow declarations - not just a one hit wonder?
  • Boult Wade Tennant LLP
  • United Kingdom
  • July 9 2018

On 28 June, the UK Court of Appeal granted permission for GSK to pursue their claim for Arrow relief in the case of Glaxo Group Limited & Ors v


Roundup of Recent Congressional Hearings, Markups on Health Policy Issues
  • Reed Smith LLP
  • USA
  • July 5 2018

Congressional committees have held numerous hearings and markups in recent weeks on health policy topics, including several hearings focused on health